Zifi-CV 200 Tablet

Brand Name

Zifi-CV 200

Generic Name / Composition

• Cefixime 200 mg (3rd Generation Cephalosporin Antibiotic)

• Clavulanic Acid 125 mg (Beta-lactamase Inhibitor)

Main Category

• Antibiotic Combination (Cephalosporin + Beta-lactamase Inhibitor)

Description

Zifi-CV 200 Tablet is a broad-spectrum antibiotic combination of Cefixime + Clavulanic Acid.

• Cefixime kills bacteria by inhibiting cell wall synthesis.

• Clavulanic Acid prevents bacterial resistance by blocking beta-lactamase enzymes.

This makes the combination more effective against resistant bacterial infections.

Uses / Indications

• Respiratory tract infections (pharyngitis, tonsillitis, bronchitis, pneumonia)

• ENT infections (sinusitis, otitis media)

• Urinary tract infections (UTI)

• Typhoid fever (Salmonella infections)

• Skin & soft tissue infections

• Infections caused by beta-lactamase producing bacteria

Dosage (General Guidance)

(As directed by physician)

• Adults: 1 tablet twice daily (depending on infection severity)

• Children (>12 yrs): Dose adjusted as per weight; younger children given syrup forms

• Duration: Typically 5–14 days

Route: Oral
Advice: Take after meals to reduce stomach irritation and improve absorption

Side Effects

• Diarrhea, nausea, vomiting, abdominal pain

• Loose stools due to gut flora changes

• Rash, itching (allergy)

• Rare: Severe allergy, liver enzyme elevation, blood count changes

Precautions / Warnings

• Not effective in viral infections (cold, flu)

• Avoid in patients allergic to penicillin or cephalosporins

• Caution in liver/kidney impairment

• May cause diarrhea → probiotic may be advised

• Complete the full prescribed course to prevent resistance

Drug Interactions

• Antacids (reduce Cefixime absorption)

• Warfarin (↑ bleeding risk)

• Probenecid (↑ Cefixime concentration)

Packaging

• Strip of 10 tablets

Manufacturer

FDC Limited
Mumbai, India